Plans by Indian drugmaker Gennova to launch its generic clot-buster tenecteplase as a treatment for stroke in India are "incomprehensible," according to a leading stroke expert. Originally developed ...

Boehringer Ingelheim’s Metalyse (tenecteplase) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment option for acute ischaemic stroke (AIS) in adults.

A drug that breaks up blood clots and prevents new clots from forming has been recommended by the National Institute for Health and Care Excellence (NICE) for adult patients with acute ischaemic ...

Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator – which ...